Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William T Toler

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 21, 2015
Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthmaDavid I Bernstein, Eric D Bateman, Ashley Woodcock, et al.
The European Respiratory Journal|October 19, 2013
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthmaPaul M O'Byrne, Eugene R Bleecker, Eric D Bateman, et al.
Journal of Negative Results in Biomedicine|June 15, 2014
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroidsJan Lötvall, Eric D Bateman, William W Busse, et al.
Allergy and Asthma Proceedings|May 26, 2009
Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergyCharles P Andrews, Bruce G Martin, Robert L Jacobs, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 21, 2015
Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthmaDavid I Bernstein, Eric D Bateman, Ashley Woodcock, et al.
The European Respiratory Journal|October 19, 2013
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthmaPaul M O'Byrne, Eugene R Bleecker, Eric D Bateman, et al.
Journal of Negative Results in Biomedicine|June 15, 2014
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroidsJan Lötvall, Eric D Bateman, William W Busse, et al.
Allergy and Asthma Proceedings|May 26, 2009
Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergyCharles P Andrews, Bruce G Martin, Robert L Jacobs, et al.
Pageof 1